Expresses Aspiration to Build an International Academic Community

Chonnam National University announced on August 12 that Professor Min Jeongjun of the College of Medicine has been elected as the next chair of the "Microbes as Therapeutics" section at the renowned Gordon Research Conference (GRC), a leading international conference in basic and advanced sciences.


Professor Min will serve as vice chair at the 2028 GRC and then lead the academic conference as chair in 2030. Professor Bahareh Behkam of Virginia Tech in the United States was also elected as co-chair. Professor Behkam is currently developing biohybrid microrobots for cancer therapy, based on micro- and nanosystems engineering.

Professor Jeongjun Min, College of Medicine, Chonnam National University.

Professor Jeongjun Min, College of Medicine, Chonnam National University.

View original image

The Gordon Research Conference operates differently from typical large-scale international academic conferences. Established at Johns Hopkins University in the United States in 1931, the GRC not only presents the latest research results but also places its core philosophy on allowing researchers to freely discuss cutting-edge studies and new ideas that have yet to be published as papers. Today, more than 395 conferences are held in various fields worldwide each year, with about 40,000 scientists participating.


The chair of the GRC does far more than merely run the academic meeting. Chairs are responsible for setting the program themes, inviting leading researchers from around the world as speakers, reviewing participant applications, and identifying new researchers and next-generation scientists, thereby shaping the international agenda and researcher networks for the field. Traditionally, the next vice chairs in each field are selected by conference participants during the event; the official program even includes a section titled "Nominations for the Next Vice Chair(s)" and the selection process.


As such, the election of a Korean researcher as chair in the early stages of a field’s development is not just a personal honor. It signifies that Korea is no longer merely keeping pace with the global trend in microbial therapeutics research, but is now positioned to participate in setting the future research agenda and direction.


Professor Min stated, "What impressed me most at this year’s first GRC was the researchers' passion for their fields. Even though presentations and discussions continued all day, the questions and debates lasted late into the night, which made me realize how quickly this field is advancing."


He continued, "When I began research using bacteria for cancer treatment about 20 years ago, it was a very small field. Now, an independent Gordon Research Conference brings together outstanding researchers from around the world."



"As an early-stage chair of this conference, I hope to go beyond my own research to discover the next generation of researchers, and to contribute to creating an international academic community where new scientific questions foster connections among researchers and ultimately improve human life," he added.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing